InnoModels Biotechnology: iHuPDX Platform Features and Advantages
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-06-24 15:25
- Views:
(Summary description)In the field of cancer treatment, finding efficient and accurate treatment solutions has always been the common pursuit of researchers and doctors. With the rapid development of biotechnology, InnoModels Biotechnology has injected new vitality into the development of individualized precision medicine with its unique iHuPDX platform. In this article, we will introduce the features and advantages of the iHuPDX platform of InnoModels Biotechnology in detail, in order to provide readers with a more comprehensive understanding.
InnoModels Biotechnology: iHuPDX Platform Features and Advantages
(Summary description)In the field of cancer treatment, finding efficient and accurate treatment solutions has always been the common pursuit of researchers and doctors. With the rapid development of biotechnology, InnoModels Biotechnology has injected new vitality into the development of individualized precision medicine with its unique iHuPDX platform. In this article, we will introduce the features and advantages of the iHuPDX platform of InnoModels Biotechnology in detail, in order to provide readers with a more comprehensive understanding.
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-06-24 15:25
- Views:
In the field of cancer treatment, finding efficient and accurate treatment solutions has always been the common pursuit of researchers and doctors. With the rapid development of biotechnology, InnoModels Biotechnology has injected new vitality into the development of individualized precision medicine with its unique iHuPDX platform. In this article, we will introduce the features and advantages of the iHuPDX platform of InnoModels Biotechnology in detail, in order to provide readers with a more comprehensive understanding.
Platform features:
1. Personalized Tumor Models
The core technology of the iHuPDX platform of InnoModels Biotechnology lies in its ability to form individualized tumor models that are highly close to the actual situation of patients based on the xenotransplantation technology of individual tumor cells of patients. This technology collects cancer tissue samples from patients and transplants them into animals such as mice to form individualized transplanted tumors. Compared with traditional tumor models based on standardized cell lines or tissue samples, the iHuPDX platform can more accurately simulate the growth, metastasis, and drug response of the patient's tumor, providing strong support for precision medicine.
2. High accuracy
Since the iHuPDX platform is directly derived from patients' tumor cells, it can more accurately simulate the characteristics of patients' tumors. This allows researchers to test the response of different drugs to a specific patient's tumor on the model and predict the efficacy and possible side effects of the drug in the patient. This predictive ability allows physicians to select the most appropriate drug combination and dosage for a patient before treatment, increasing the success rate of treatment and reducing unnecessary risks.
3. Stable and Reliable
With advanced primary cell inoculation technology, the iHuPDX platform is able to achieve early and uniform growth, ensuring that efficacy experiments are conducted within the optimal window. At the same time, the homogenization of the same batch of samples is guaranteed through the cell suspension modeling approach, resulting in a high degree of consistency in the growth rate and biological characteristics of the model. This stability not only ensures the reliability of the experimental results, but also reduces the experimental and time costs.
Platform Advantages:
1. Leading the new trend of individualized precision medicine
The iHuPDX platform of InnoModels Biotechnology is leading the new trend of individualized precision medicine with its unique individualized tumor model technology. In the field of cancer treatment, individualized treatment plans have become an inevitable trend for future development. The iHuPDX platform is a powerful promoter of this trend, providing cancer patients with more accurate and effective treatment options.
2. Promoting tumor immunotherapy research
In addition to supporting individualized precision medicine, the iHuPDX platform also demonstrates significant advantages in tumor immunotherapy research. By combining the iHuPDX platform with a humanized model of the PBMC immune system, researchers can simulate the interactions between tumors and the immune system, gain a deeper understanding of the immune mechanisms of tumors, and develop new immunotherapies. This combination enables the iHuPDX platform to have a wide range of applications in the field of tumor immunotherapy.
3. Improving the efficiency of new drug development
The iHuPDX platform of InnoModels Biotechnology provides strong support for new drug development with its high-throughput generic clinical research platform. With the help of this platform, researchers can conduct high-throughput clinic-like efficacy testing of drugs at an early stage, so as to quickly screen out potential drug candidates. This highly efficient R&D process not only reduces the cost and time of new drug development, but also improves the success rate of R&D.
In conclusion, with its unique individualized tumor modeling technology and significant advantages, the iHuPDX platform of InnoModels Biotechnology shows a broad application prospect in the field of individualized precision medicine and tumor immunotherapy research. In the future, with the continuous development and improvement of this technology, we believe that it will play an even more important role in the field of cancer treatment and bring hope and gospel to more patients.
- Tel 15010000264
- E-mail limy@imodels.tech
- Tel 13810723384
- Top
InnoModels Biotechnology (Beijing) Co., Ltd.
TEL:15010000264 13810723384
Email:cndw@imodels.tec
Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing
Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company